| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EXTENDED REPORT |
1 Department of Internal Medicine University Medical Centre St Radboud, Nijmegen, The Netherlands
2 Department of Rheumatology, University Medical Centre St Radboud, Nijmegen, The Netherlands
Correspondence to:
Correspondence to:
Professor J W M van der Meer
Department of Internal Medicine (541), UMC St Radboud, PO Box 9101, 6500HB Nijmegen, The Netherlands; j.vandermeer{at}aig.umcn.nl
Background: Leptin regulates food intake and modulates immunity and inflammation. A positive feedback mechanism has been described between tumour necrosis factor (TNF) and leptin, and it has been suggested that leptin potentiates inflammation in patients with rheumatoid arthritis (RA).
Objective: To assess whether inflammation correlates with leptin concentrations in patients with RA, and whether anti-TNF treatment modulates leptin concentrations in these patients.
Methods: Leptin, IL6 and CRP were measured (at baseline and after 2 weeks of treatment) in the blood of 31 patients with RA starting either anti-TNF treatment or placebo, and in 18 healthy controls.
Results: In patients with RA, plasma leptin concentrations at baseline correlated inversely with the degree of inflammation as assessed by C reactive protein (CRP; rs2 = 0.21, p<0.01) or interleukin (IL) 6 concentrations (rs2 = 0.22, p<0.008). Mean (SD) leptin concentrations did not differ between patients with RA and controls (6.0 (4.6) v 4.2 (2.8) ng/ml in men; 15.1 (7.9) v 13.4 (5.2) ng/ml in women). Short course anti-TNF treatment for 2 weeks did not modify leptin concentrations, despite significant reduction of CRP and IL6.
Conclusion: A significant inverse correlation between inflammation and leptin concentrations was found in patients with active RA, although plasma leptin concentrations did not significantly differ from those in healthy controls. This suggests that active chronic inflammation may lower plasma leptin concentrations. Two weeks’ treatment with anti-TNF did not change plasma leptin concentrations and longer treatment may be needed to see an effect on leptin.
Abbreviations: BMI, body mass index; CRP, C reactive protein; DMARDs, disease modifying antirheumatic drugs; IL, interleukin; RA, rheumatoid arthritis; TNF
, tumour necrosis factor
Keywords: leptin; inflammation; rheumatoid arthritis; anti-tumour necrosis factor treatment
This article has been cited by other articles:
|
|
 |
|
  A I Martin, E Castillero, M Granado, M Lopez-Menduina, M A Villanua, and A Lopez-Calderon Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis J. Endocrinol., April 1, 2008; 197(1): 111 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Liu, P Yang, H He, X Lin, L Jiang, W Chi, C Zhao, and H Zhou Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion Br. J. Ophthalmol., April 1, 2008; 92(4): 557 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thewissen and J. W. Cohen Tervaert Leptin and ANCA-associated vasculitis: a healthy link? Rheumatology, April 1, 2008; 47(4): 387 - 389. [Full Text] [PDF]
|
|
|
|
|
|
P. Kumpers, R. Horn, G. Brabant, A. Woywodt, M. Schiffer, H. Haller, and M. Haubitz Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis Rheumatology, April 1, 2008; 47(4): 484 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tang, K. Kitisin, W. Jogunoori, C. Li, C.-X. Deng, S. C. Mueller, H. W. Ressom, A. Rashid, A. R. He, J. S. Mendelson, et al. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-{beta} and IL-6 signaling PNAS, February 19, 2008; 105(7): 2445 - 2450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. ALEXANDRAKI, C. PIPERI, C. KALOFOUTIS, J. SINGH, A. ALAVERAS, and A. KALOFOUTIS Inflammatory Process in Type 2 Diabetes: The Role of Cytokines Ann. N.Y. Acad. Sci., November 1, 2006; 1084(1): 89 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Otero, R Lago, R Gomez, F Lago, C Dieguez, J J Gomez-Reino, and O Gualillo Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis Ann Rheum Dis, September 1, 2006; 65(9): 1198 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler Role of Adipose Tissue as an Inflammatory Organ in Human Diseases Endocr. Rev., August 1, 2006; 27(5): 449 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Otero, R. Lago, R. Gomez, C. Dieguez, F. Lago, J. Gomez-Reino, and O. Gualillo Towards a pro-inflammatory and immunomodulatory emerging role of leptin Rheumatology, August 1, 2006; 45(8): 944 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Harle, P Sarzi-Puttini, M Cutolo, and R H Straub No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis, July 1, 2006; 65(7): 970 - 971. [Full Text] [PDF]
|
|
|
|
|
|
P. HARLE and R. H. STRAUB Leptin Is a Link between Adipose Tissue and Inflammation Ann. N.Y. Acad. Sci., June 1, 2006; 1069(1): 454 - 462. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
